Catalyst Wire Dossier Catalyst Wire Dossier

DTPa/Hib Vaccine

diphtheria-tetanus-pertussis acellular and Haemophilus influenzae type b conjugate vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTPa/Hib Vaccine, covering 2016-10-12 to 2016-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age [Phase 3]

See pricing